Tivicay: uses, dosage, safety, and treatment guidance

Tivicay is a HIV-1 integrase strand transfer inhibitor containing dolutegravir used to treat HIV-1 infection as part of a complete antiretroviral regimen. The active ingredient is tivicay, marketed in various regions under Tivicay and Tivicay PD.

• Indications: HIV-1 treatment in eligible adults and children, including selected integrase-inhibitor-resistant infection under specialist management.
• Dosage: once or twice daily depending on age, weight, resistance, and interacting medicines; pediatric dispersible dosing is weight-based.
• Contraindications: hypersensitivity to dolutegravir or concurrent dofetilide therapy because dolutegravir can raise dofetilide exposure.

What is Tivicay used for?

Tivicay is prescribed for carefully selected patients when its expected clinical benefit outweighs its condition-specific risks.

HIV-1 treatment in eligible adults and children, including selected integrase-inhibitor-resistant infection under specialist management. Diagnosis matters because similar symptoms can arise from conditions that need different treatment. A prescriber considers medical history, current medicines, examination findings, laboratory data, and treatment goals before choosing this drug.

How does Tivicay work?

Dolutegravir binds the HIV integrase active site and blocks strand transfer of viral DNA into the host-cell genome. This interrupts replication, lowers plasma viral load, and permits immune recovery when combined with other effective antiretrovirals.

The pharmacologic effect does not make the medicine suitable for every person with similar symptoms. Patients who plan to buy Tivicay should verify the diagnosis and prescription first, because Tivicay price cannot substitute for clinical selection, monitoring, or authentic supply.

How should Tivicay be taken or used?

Take exactly as part of the full antiretroviral regimen and do not stop independently. Separate aluminum- or magnesium-containing antacids; calcium and iron may be taken together with food or separated as directed. Dispersible and film-coated tablets are not milligram-for-milligram interchangeable.

Read the dispensing label every time, use the correct measuring or administration device, and never share prescription medicine. Contact the care team before changing the schedule, crushing a dosage form, switching formulations, or stopping long-term therapy.

Which Tivicay dosage variants are available?

Common marketed variants include 10 mg, 25 mg, and 50 mg film-coated tablets and 5 mg dispersible tablets for oral suspension.

Availability and licensed indications differ by country and manufacturer. When comparing where to buy Tivicay 10 mg, 25 mg, and 50 mg film-coated tablets and 5 mg dispersible tablets for oral suspension, confirm the precise strength, dosage form, route, and package directions rather than choosing by Tivicay price alone. Products with different release characteristics, concentrations, or routes may not be interchangeable.

What are the most common side effects of Tivicay?

The more frequently reported effects include insomnia, headache, fatigue, nausea, diarrhea, and weight gain.

Not every patient experiences these reactions, and their likelihood depends on dose, formulation, duration, health status, and other medicines. Record when symptoms begin and whether they follow a dose. Persistent, worsening, or function-limiting effects should be discussed rather than managed by an unapproved dose change.

Which serious effects require urgent medical care?

Seek prompt care for rash with fever, blistering, facial swelling, breathing difficulty, jaundice, dark urine, severe depression, or suicidal thoughts. Hypersensitivity and liver injury can be severe, particularly with hepatitis B or C coinfection.

Emergency warning signs should not be watched at home while waiting for the next routine appointment. Bring the medication package and a current medicine list when seeking urgent help so clinicians can identify the active ingredient, strength, and possible interaction.

Which medicines and substances interact with Tivicay?

Dofetilide is contraindicated. Rifampin, carbamazepine, oxcarbazepine, phenytoin, phenobarbital, St John’s wort, polyvalent-cation antacids, iron, calcium, certain HIV medicines, and metformin can change exposure or require timing and dose adjustments.

Give the prescriber and pharmacist a complete list of prescription drugs, nonprescription products, vitamins, supplements, and recreational substances. Interaction risk can arise when another drug is started, stopped, or dose-adjusted, even after a stable period on treatment.

Can Tivicay be used with alcohol?

Alcohol advice depends on the indication, formulation, organ function, and other medicines, so an individualized recommendation is safer than assuming that moderate use is harmless.

Alcohol may worsen dizziness, sedation, dehydration, low blood pressure, impaired glucose control, gastrointestinal irritation, or liver stress where those effects are relevant. Avoid alcohol when the prescriber or product information advises it, and never drive when treatment or alcohol impairs alertness.

Is Tivicay safe during pregnancy or breastfeeding?

Effective HIV therapy should continue through pregnancy under specialist care; registry and clinical data support individualized dolutegravir use. Breastfeeding guidance depends on local HIV recommendations and transmission risk.

Tell the prescriber about pregnancy plans, a positive test, breastfeeding, or fertility concerns before treatment whenever possible. Exposure decisions should consider gestational timing, dose, route, untreated disease, safer alternatives, and infant factors.

What monitoring is needed during Tivicay treatment?

Measure HIV RNA and CD4 count, assess adherence and resistance, and monitor liver enzymes, hepatitis coinfection, weight, glucose, mental health, kidney markers, and interactions. A small creatinine rise may reflect inhibited tubular secretion rather than reduced filtration.

Keep scheduled reviews and report new symptoms between visits. Monitoring is intended to detect loss of effectiveness, organ toxicity, interaction effects, and the need for dose adjustment before a preventable complication becomes severe.

What should be done after a missed dose or overdose?

Take a missed dose when remembered unless the next is near, without doubling. Overdose has no specific antidote and requires clinical monitoring and supportive care.

Do not induce vomiting or improvise a corrective dose. Exact advice depends on the amount, time, formulation, symptoms, age, and medical history, so provide those details promptly to a poison center or emergency clinician.

How should Tivicay be stored and obtained?

Store each formulation in its original tightly closed bottle at labeled room temperature; keep any supplied desiccant in place and protect dispersible tablets from moisture.

Before deciding to buy Tivicay, confirm the authorized dosage form, intact packaging, expiration date, and required monitoring. Tivicay price should remain secondary to prescription accuracy, storage integrity, and licensed dispensing.

People who buy Tivicay should use a licensed pharmacy and contact a qualified clinician if the supplied product differs from the prescription or expected appearance.

Medical information disclaimer

This page provides general education and does not replace diagnosis, prescribing, monitoring, or emergency care. Follow the instructions supplied by the treating clinician and the medicine’s approved local labeling.